Provided by Tiger Fintech (Singapore) Pte. Ltd.

PolyPid Ltd.

3.16
-0.0999-3.06%
Volume:57.07K
Turnover:181.26K
Market Cap:50.24M
PE:-0.79
High:3.26
Open:3.26
Low:3.07
Close:3.26
Loading ...

PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025

GlobeNewswire
·
30 Jul

PolyPid files to sell 7.63M ordinary shares for holders

TIPRANKS
·
30 Jul

PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Diabetes and Weight Loss Market

GlobeNewswire
·
15 Jul

PolyPid Approves Key Resolutions at Annual Shareholder Meeting

TIPRANKS
·
26 Jun

PolyPid Is Maintained at Buy by Roth Capital

Dow Jones
·
19 Jun

PolyPid Is Maintained at Market Outperform by JMP Securities

Dow Jones
·
17 Jun

PolyPid price target lowered to $9 from $12 at Roth Capital

TIPRANKS
·
17 Jun

PolyPid (PYPD) Receives a Buy from Craig-Hallum

TIPRANKS
·
17 Jun

PolyPid Secures $26.7 Million Post-Successful Phase 3 Trial

TIPRANKS
·
17 Jun

PolyPid price target lowered to $14 from $16 at Citizens JMP

TIPRANKS
·
17 Jun

Press Release: PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results

Dow Jones
·
17 Jun

PolyPid (PYPD) Gets a Buy from Roth MKM

TIPRANKS
·
10 Jun

PolyPid Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
09 Jun

PolyPid’s D-PLEX100: Compelling Phase 3 Results and Strong Commercial Prospects Justify Buy Rating

TIPRANKS
·
09 Jun

BUZZ-PolyPid rises after treatment to prevent surgical site infections meets late-stage trial goal

Reuters
·
09 Jun

BRIEF-PolyPid Says D-PLEX (100) Meets Primary Efficacy Endpoint In Phase 3 Trial

Reuters
·
09 Jun

PolyPid announces topline results from Phase 3 SHIELD II trial

TIPRANKS
·
09 Jun

PolyPid Ltd. Announces Plans to Submit NDA to FDA for D-PLEX100 in Early 2026 Following Positive Phase 3 Trial Results

Reuters
·
09 Jun

PolyPid Initiated at Buy by Roth Capital

Dow Jones
·
06 Jun

Roth Capital Initiates PolyPid at Buy With $9 Price Target

MT Newswires Live
·
05 Jun